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Abstract 
There has been an emerging interest in designing novel, biocompatible materials that can 
selectively undergo morphological transitions to accumulate at a cancer site in response to 
specific stimuli. One such stimulus is the acidic extracellular pH (6.6–7.0) of tumor tissue. 
Developing a magnetic resonance imaging (MRI) contrast agent that can self-assemble into a 
larger, more slowly diffusing entity only in the acidic extracellular pH would provide sufficient 
accumulation at the tumor site to allow it to selectively target all cancers and increase MRI 
resolution about the disease site. There is a significant challenge in achieving such a transition in 
vivo without understanding how the contrast agent structure can affect the self-assembly process. 
Here, we characterize the tunable self-assembling behavior of six peptide amphiphiles (PAs) 
from spherical micelles at higher pHs to cylindrical nanofibers at lower pHs. The molecular 
structure of each PA varies in the hydrophobic core, β-sheet forming, or charged region to assess 
how these changes affect self-assembly. The morphological pH and concentration dependence of 
the PAs was monitored in an isotonic salt solution mimicking that of blood serum using Critical 
Aggregation Concentration measurements and Circular Dichroism Spectroscopy. Moreover, the 
T1 Relaxivity of the PAs was obtained to observe how morphological changes affect relaxation 
rates. It was found that increasing the length of the alkyl-tail, increasing the relative strength of 
the β-sheet forming region, and decreasing the relative strength of the charged region all function 
to increase the pH of transition, and vice-versa. These results provide a framework for 
optimizing PA structure to create a novel, pan-cancer, increased-resolution MRI contrast agent. 
 
 
 
Chapter 1: Introduction 
 
The American Cancer Society 1,700,000 new cases of cancer are expected to be 
diagnosed in the United States in 2016, and 13.0 million deaths are expected annually by 2030
1
. 
Accordingly, there has been a tremendous interest in developing new technologies to detect and 
treat cancer. Indeed, the National Institute of Health (NIH) estimates that 5.65 billion dollars will 
be spent in 2016 on cancer research
2
. A developing area of research is the use of specific 
biomarkers, such as hepsin in prostate cancer or CDX2 in colon cancer, as targets for drug 
delivery
3,4
. The World Health Organization (WHO) defines a biomarker as “any substance, 
structure, or process that can be measured in the body or its products and influence or predict the 
incidence of outcome or disease
5.”One such biomarker of cancer is the acidic extracellular 
environment surrounding the leaky vasculature of tumor tissue, caused by rapid growth and an 
increased rate of glycolysis
6,7
. This acidic environment of pH 6.6 – 7.2 is lower than that of 
normal physiological pH of 7.4. By exploiting these characteristics, a novel class of cancer-
imaging materials can be developed. Specifically, a magnetic resonance imaging (MRI) contrast 
agent that can self-assemble into a larger, more slowly diffusing entity only in the acidic 
extracellular pH would provide sufficient accumulation to allow it to selectively target all 
cancers and increase MRI resolution about the disease site. 
Peptide amphiphiles (PAs) are of interest due to their capacity to exist in a variety of 
morphologies, such as individual molecules, spherical micelles, or cylindrical nanofibers, 
depending on their concentration and environmental pH. We have previously demonstrated the 
ability of PAs to undergo a pH-triggered morphological transition in vitro from spherical micelle 
to cylindrical nanofiber in a serum that mimics that of tumor tissue
8
. This transition provides a 
diffusion-limited morphology that increases the local concentration of PAs at the disease site. 
Figure 1 provides an overview of this mechanism.  However, there is a significant challenge in 
achieving such a transition in vivo without understanding how the contrast agent structure can 
affect the self-assembly process, due to the various buffers and macromolecules present in 
organisms. To this end, we characterize the tunable self-assembling behavior of six peptide 
amphiphiles (PAs) from spherical micelles at higher pHs to cylindrical nanofibers at lower pHs. 
The molecular structure of each PA varies in the hydrophobic core, β-sheet forming, or charged 
region to assess how these changes affect self-assembly. 
 
 
Figure 1: Representation of PA’s morphological transition 
in response to their environment 
 
The transition from micelle to nanofiber is necessary to take advantage of the enhanced 
permeability and retention (EPR) effect, which is a property of tumor tissue which allows the 
increased accumulation of small molecular aggregates due to the tissue’s underdeveloped 
vascularization resulting from rapid tissue growth
9
. Micelles with diameters near 10 nm will be 
able to take advantage of the EPR effect, whereas their assembly into larger nanofibers with 
lengths in the micrometer range will be sterically hindered and unable to diffuse out of the 
disease site. However, a molecule that can successfully transition in vitro may not necessary 
transition similarly in vivo. To this end, a more comprehensive understanding of how one can 
chemically tune the structure of PAs to affect their self-assembling function is necessary.  
A typical PA consists of a hydrophobic alkyl tail and an amino acid sequence. Here, the 
amino acid sequence is composed of a more hydrophobic, β-sheet forming region, and a charged 
region of comparable size. We also attach a Gd
3+
 chelated 1,4,7- 
tris(carboxymethylaza)cyclododecane-10-azaacetylamide (DO3A) moiety to allow the molecules 
to be MRI active
10
. The length of the alkyl tail and the propensity of the β-sheet forming region 
to form β-sheet promotes the formation of nanofibers, whereas the relative strength of the 
charged region is primarily responsible for the formation of micelles under more basic 
conditions. All four aspects of the PAs (the alkyl tail, β-sheet forming region, charged region, 
and MRI region) affect the self-assembly process. A schematic representation of one of the PAs 
studied is provided in Figure 2. 
 
Figure 2: A colored representation of the structure of a peptide amphiphile 
 
The attractive, nanofiber promoting forces and the repulsive, micelle promoting forces 
must be balanced in order to produce a molecule that can successfully transition in vivo at an 
acidic pH found within tumor tissues. To this end, we have previously synthesized and 
characterized four PAs, varying the alkyl chain length, number of glutamic acids (E) in the 
charged region, and the substitution of tyrosine (Y) to alanine (A) in the β-sheet forming region. 
However, a more thorough understanding of how these structural changes affects transition 
required the characterization of two more PAs. The list of PAs synthesized and characterized are 
provided in Table 1. The scope of this project focuses on the synthesis and construction of phase 
diagrams of PAs 5 and 6, that is, pentadecyl-YAAAEEEEK(DO3A:Gd)-NH2 and palmitoyl-
YAAAEEEEEK(DO3A:Gd)-NH2. Moreover, further characterization via T1 relaxivity and 
dynamic light scattering (DLS) was acquired for PAs 1 – 6.  
 
 
PA # 
 
 
Structure 
 
PA 1 
 
 
palmitoyl-YYAA-EEEE-K[DO3A:Gd] 
 
 
PA 2 
 
 
palmitoyl-YYAA-EEEEE-K[DO3A:Gd] 
 
 
PA 3 
 
 
pentadecyl-YYAA-EEEE-K[DO3A:Gd] 
 
 
PA 4 
 
 
palmitoyl-YAAA-EEEE-K[DO3A:Gd] 
 
 
PA 5 
 
 
palmitoyl-YAAA-EEEEE-K[DO3A:Gd] 
 
 
PA 6 
 
 
pentadecyl-YAAA-EEEE-K[DO3A:Gd] 
 
 
Table 1: PAs characterized. 
Emphasis on how PAs 2 – 6 change from PA 1. 
 
 
 
 
 Chapter 2: Phase Diagrams of PAs 5 & 6 
 
The PAs of this project were synthesized via solid-phase peptide synthesis using Fmoc 
chemistry and purified via preparatory scale reverse-phase high performance liquid 
chromatography (HPLC)
11
. Their purity was assayed via electrospray ionization time-of-flight 
mass spectrometry (ESI-TOF MS). The phase diagrams of PAs 1 – 4, including CD and CAC 
measurements, were previously determined by Nicholl
12
. Accordingly, this project aims to 
further elucidate structure-function relationships via determination of the phase diagrams of PAs 
5 & 6. As discussed by Nicholl, palmitoyl-YYAAEEEEK(DO3A:Gd)-NH2 (PA 1) exclusively 
formed nanofibers over micelles or individual molecules across all pHs and concentrations 
examined, due to the molecule’s dual tyrosine (Y) residues which exhibit a high β-sheet forming 
propensity
13
. Therefore, the goal of characterizing PAs 2 – 6 was to decrease the attractive 
forces. This was accomplished by adding an additional glutamic acid (E) to the charged region 
for PA 5, and removing a methylene group in the hydrophobic region for PA 6. For all 
measurements, PAs were dissolved in a 150 mM NaCl, 2.2 mM CaCl2 simulated serum salt 
solution to replicate the electrostatic environment found in animal plasmas. 
Because the PAs studied can exist as three different morphologies, a combination of 
Circular Dichroism (CD) and Critical Aggregation Concentration (CAC) were used to construct 
phase diagrams illustrating the pH and concentration dependence of the PAs. CD was used to 
gauge the morphology transition between spherical micelles and cylindrical nanofibers.  On the 
CD graph, the micelle morphology is specified by the characteristic “random coil” spectrum, 
indicated by a relatively mild local maximum around 218 nm. The nanofiber morphology is 
specified by the characteristic “β-sheet” spectrum, indicated by a more intense local minimum 
around 218 nm. Because the transition between the two morphologies is not dichotomous and 
exact, the working definition of a transition as detected by CD is when the first β-sheet spectrum 
crosses the x-axis at 205 nm, which was previously confirmed by fluorescence anisotropy
14
. 
CAC was used to gauge the concentration at which PA aggregated from individual molecules 
into either micelles or nanofibers using the pyrene 1:3 method
15
. On the CAC graph, the CAC is 
determined where there is a change in slope of the ratio of the first and third (I376/I392) emissions 
of pyrene when excited at 335nm. The change in slope of I376/I392 is the result of the 
encapsulation of pyrene into the micelles or nanofibers at higher concentrations. The phase 
diagrams of PAs 5 & 6 are provided in Figure 3.  
 
 
 
 
 
 
 
Figure 3: Concentration and pH dependent phase diagrams of PA 5 (right) 
 and PA 6 (left). Blue lines correspond to CD data, and red lines correspond to CMC data. 
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 Chapter 3: Comparison of Phase Diagrams 
 
I) Circular Dichroism 
 The transition from spherical micelles at more basic pHs to cylindrical nanofibers at more 
acidic pHs is crucial to the development of this class of imaging-vehicle delivery. For PA 1, 
there was no observable transition from CD across a wide range of pH values and concentrations. 
However, micelle to nanofiber pH dependent transitions did occur in PAs 2 – 5. A comparison of 
this CD transitional pHs for the five molecules is provided in Figure 4.  
 
Figure 4: CD data for PAs 2 – 6 
 
 From this data, we can see that there is a concentration dependence on their pH of 
transition, especially at more basic pHs, most notably in PA 6. This concentration dependence 
has been noted in the past, albeit to a lesser extent, which is not desirable in a delivery vehicle. 
Other PAs, such as palmitoyl-IAAAEEEEK(DOTA:Gd) and palmitoyl-
MAAAEEEEK(DOTA:Gd), are better suited for this contrast imaging delivery method due to 
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their relative concentration independence. Therefore, this concentration dependence may be due 
to the presence of the amphipathic tyrosine residues in the β-sheet forming region. Tyrosine’s 
side group both contains an aromatic ring and a hydroxyl group, which could influence self-
assembly due to pi-pi interactions and hydrogen bonding interactions, respectively. 
 Because comparisons between PAs 2 – 4 are provided by Nicholl, this discussion will 
focus on comparisons between PA 5 with PAs 2 – 4, PA 6 with PAs 2 – 4, and PA 5 with PA 6. 
Out of the YAAA PAs (PAs 4 – 6), PA 5 containing an extra glutamic acid, has the most acidic 
pH of transition. Coupled with the fact that out of the YYAA PAs (PAs 1 – 3), PA 2 containing 
an extra glutamic acid, has the most acidic pH of transition, we can see that adding a glutamic 
acid lowers the pH of transition, and therefore serves as a repulsive force to form micelles over 
nanofibers.   
 Interestingly, PA 6’s CD shows that out of the YAAA PAs (PAs 4 – 6), it has the 
strongest preference to form nanofibers over micelles. There is evidence that the deletion of a 
methylene group is certainly a repulsive force because PA 1 contained the longer palmitoyl alkyl 
chain and was always nanofibers, whereas PAs 3 and 6 contained the shorter pentadecyl alkyl 
chain and both exhibited transitions into micelles at some pH. Therefore, for YAAA PAs, the 
addition of an extra glutamic acid has greater influence on the nanofiber forming ability of the 
PA than the deletion of a methylene group. The most confounding data in this study is the fact 
that PA 6 appears to form nanofibers more preferentially than PA 4, which has the same amino 
acid sequence but the palmitoyl alkyl chain. It may also be the case that the relative inability of 
the pentadecyl alkyl chain to undergo a hydrophobic collapse disproportionately alters the 
desolvation cost of the β-sheet forming region to prefer a β-sheet configuration, which is not 
seen in PA 3 due to the presence of the second tyrosine, which is better solvated by water due to 
the free hydroxyl group on the side chain. Admittedly, the difficulty of trying to explain this 
phenomenon is not lost, and a more likely candidate is simply that the data points from the PA 6 
CD are errant. Ideally, the CD curve on the phase diagram would be above PA 4 and below PA 
6, which would indicate a proper loss of attractive forces by the presence of the pentadecyl and 
β-sheet amino acid subsitutions. 
 
II) Critical Aggregation Concentrations 
 By using CAC, we can determine the propensity for PAs to form micelles or nanofibers 
versus individual molecules. These measurements provide information regarding the minimum 
concentration needed to inject into a test subject to achieve enhanced resolution via MRI. Ideally, 
PAs would exist in the micelle morphology at the physiological pH of 7.4. Figure 5 shows a 
comparison of CAC measurements for PAs 2 – 5, as the CAC of PA 1 was below the detectable 
limit.  
 
Figure 5: An overlay of the CACs of PAs 2 – 6 
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 Foremost, this data shows that PAs 2 – 5 do aggregate from individual molecules into 
nanofibers or micelles at pH 5 – 9. This is evidence of reduced attractive forces due to the 
structural changes imposed. PAs 2 & 3 have two tyrosines in their β-sheet forming regions, as 
opposed to the singular tyrosine in PAs 4 – 6. The increased hydrophobic interactions caused by 
the extra tyrosine allow PAs 2 & 3 to self –assemble easier. Accordingly, at pH 5 – 8, the CAC 
of PAs 2 & 3 are both lower than those of PAs 4 – 6. However, at pH 9, PA 3 has the highest 
CAC, followed by PA 2. At this pH, the glutamic acids in the charged region will be largely 
deprotonated and exhibit a negative charge, which can serve as a repulsive force. Interestingly, 
we do not see this behavior in PAs 4 – 6. Therefore, there is evidence that this CAC discrepancy 
is caused by the deprotonation of the two tyrosines due to the approach of the pH to its pKa of 
10.07. 
 We can also see that the CAC for all PAs is lowest at pH 5. Moreover, for PAs 4, 5, and 
6, there is a relatively large jump between the CACs of pH 5 and 6. This may be due to the 
morphology that the individual molecules are aggregating into. At low concentrations, the pH of 
transition for most PAs is near 5.5. This is most directly illustrated by PAs 4 and 5. Therefore, it 
may be the case that the PAs are assembling into nanofibers in the pH range 5 – 6 and have a 
stronger propensity to form nanofibers than micelles at this pH.  
 We can see that the deletion of a methylene group has less influence over the CAC than 
adding a glutamic acid. For instance, the CAC of PA 1 was below the detectable limit, and at 
pHs 5 – 8, PA 3 also had the lowest CACs for PAs 2 – 6. Similarly, PA 6 had a slightly higher 
CAC than PA 4 at pH 6 – 9, indicating that the deletion of the methylene was indeed a repulsive 
force for the transition between individual molecules and an aggregate, but less so than adding a 
glutamic acid. 
 Interestingly, whereas PA 6 preferentially formed nanofibers more than any PA other 
than PA 1, it did not have the lowest CAC. This indicates that PA 6 prefers to exist as a single 
molecule or nanofiber over a micelle, relative to the rest of the PAs. The explanation for this 
phenomenon remains to be seen. 
 
III) Phase Diagrams 
 The ability for our PAs to exist as single molecules, micelles, and nanofibers adds 
complexity to their analysis. The molecules preference for single molecules over micelles does 
not necessarily have much bearing on their preference to form micelles over nanofibers. 
However, by overlaying the phase diagrams, we can analyze the PAs preference to form each 
morphology as a function of their chemical structure. One of the limitations of this analysis is 
that PA 1 only formed nanofibers, and accordingly cannot be used to compare how its self-
assembly compares to those of other molecules. Nevertheless, comparisons can be made to 
assess how each of the structural changes – adding a glutamic acid, removing a methylene group, 
substituting a tyrosine for an alanine – affected self-assembly.  
 
Figure 6: Phase diagram overlay for PAs 4 & 5 
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  Figure 6 shows the comparison between PAs 4 & 5, with the structural change being 
adding a glutamic acid in the charged region. Going from PA 4 to PA 5, the region where 
micelles can exist expands, indicating that adding an additional glutamic acid reduces the 
attractive forces. Similarly, for pHs 6 – 9, the CAC of PA 5 is higher than that for PA 4. At pH 5, 
we can see that the CAC for PA 5 is lower than that of PA 4, which indicates that PA 5 will form 
a nanofiber more readily than PA 4. Thus, the addition of a glutamic acid may be seen as an 
attractive force only at low concentrations and pHs, which may be due to the differences in pKas 
of the carboxylic acids of the glutamic acids, which are influenced by their local environment. 
For instance, the pKa of acetic acid, a common monoprotic carboxylic acid, is 4.76 at 25 ºC. 
However, the pKas of malonic acid, a dicarboxylic acid with a methylene group between the 
carbonyls, are 2.85 and 5.70 at 25 ºC
16
. The glutamic acids in close proximity to each other 
makes it more challenging to remove subsequent protons to introduce new negative, repulsive 
charges, which in turn, allows the additional glutamic acid to function as an attractive force at 
this acidic pH. 
 
 
 
 
 
 
 
Figure 7: Phase diagram overlay for PAs 2 & 5 
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  Figure 7 shows the comparison between PAs 2 & 5, with the structural change being the 
substitution of a tyrosine for an alanine in PA 5. As with the previous comparison, the area for 
micelle region transforms. The CD curve shifts to the left, indicative of the loss of attractive 
forces offered by the second tyrosine in the β-sheet forming region. Similarly, across pHs 5 – 8, 
the CMC increases, indicative of a loss of attractive forces. As discussed previously, at the high 
CMC value at pH 9 for PA 5 may be due to the deprotonation of the tyrosines. In a similar 
manner to how the polarizable carboxylic acids’ pKas changed due to their environment, the 
tyrosines in close proximity to each other induce a gap between their two pKas – for instance, 
from the literature value of 10.07 for each tyrosine, to approximately 9 and 11.  
 
 
Figure 8: Phase diagram overlay for PAs 4 & 6 
 
 Figure 8 shows the comparison between PAs 4 & 6, with the structural change being the 
removal of a methylene group in the alkyl chain in PA 6. The CMCs are very similar, although at 
all pHs except for pH 5, PA 6 has a slightly smaller CMC. The decreased region where micelles 
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can form is unexpected, and in light of any better explanation, the CD data may have been 
incorrectly determined. The most likely candidate for error was an increased concentration of 
stock solution. Materials containing tyrosine absorb very well in the 275 to 280 nm range due to 
the aromatic groups on the side chains
17
. Therefore, some of this absorbance might be able to be 
detected at the high end of the CD absorbance, which was determined for wavelengths 190 – 260 
nm. Unfortunately, there was no indication of bleed-over in the 255 – 260 nm wavelengths for 
the CD of PA 6, so this concentration determination method cannot be used. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4: Dynamic Light Scattering 
 Dynamic Light Scattering (DLS) was employed to analyze the size of micelles. DLS uses 
the random movement, i.e., Brownian motion, of smaller particles that are faster than the 
movement of larger particles to determine the size of spherical particles. Fluctuations in the 
intensities of light scattered by the particles can be determined and the translational diffusion 
coefficient derived. Using the Stokes-Einstein equation, the hydrodynamic radius can be 
calculated. 
 The average diameters of micelle-forming PAs 2 – 6 are summarized in Figure 9. The ± 
values represent one weighted standard deviation for the error associated with collecting these 
data, and not one standard deviation of the actual size of the micelles. This is to say, for PA 2, 
the micelle most likely has a diameter of 11.26 nm, but it may be slightly bigger or smaller. The 
± values should not be interpreted as the micelles size existing on a continuum, with some being 
smaller than the average and some being larger. Accordingly, it may seem promising that PAs 3 
& 6 are smaller than PAs 1 & 4 (pentadecyl to palmitoyl, respectively), this cannot be seen as 
statistically significant. However, while this data is not exact, it provides a foundation for further 
analysis, and with a lack of other evidence present, provides information on the sizes of the 
micelles. 
 
 
 
 
 
 
 
 Diameter (nm) 
PA 2 11.26 ± 1.53 
PA 3 10.81 ± 1.56 
PA 4 10.97 ± 1.85 
PA 5 11.21 ± 1.77 
PA 6 10.75 ± 1.45 
 
 
 
Figure 9: The weighted average diameters and normalized DLS curves 
 
 Interestingly, the weighted average diameters of PAs 2 and 5 are approximately 0.3 – 0.4 
nm larger than those of PAs 3, 4, and 6. This is indicative of the presence of one additional 
glutamic acid in the charged region, as that length roughly corresponds to roughly less than the 
size of two additional amino acids, due to the diameter being composed of two PAs. Similarly, 
the weighted average diameters of PAs 3 and 6 are smaller than that of PA 4, indicative of a loss 
of a methylene group in the hydrophobic core. 
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Chapter 5: T1 Relaxivity (r1) 
 A critical component of this study is to study how well the different morphologies 
function as MRI contrast agents. In order to assess this, low-field spin−lattice (T1) values of PAs 
1 – 6 were determined in 150 mM NaCl and 2.2 CaCl2 mM aqueous solution. Three regions of 
each PA’s phase diagram were studied: the nanofibrous range below the concentration-
independent pH of transition, the high concentration nanofibrous range above the pH of 
transition, and the micellar 
range above the pH of 
transition concentration-
independent, as demonstrated 
in Figure 10. This would 
require a systematic 
determination of T1 values at a 
minimum of two pHs: a more 
acidic pH and a more 
physiologically relevant pH. At very acidic pHs < 5.0, DO3A is known to leech Gd
3+
 due to the 
protonation of the carboxylic acids chelating the metal ligand (biomac?). Bound Gd is necessary 
for inner-sphere paramagnetic relaxation about the DO3A complex, and aqueous Gd
3+
 is toxic to 
mammals
18
. Therefore, a pH of 5.2 was selected to ensure Gd
3+
 remained chelated, and because 
all PAs exist as nanofibers at this pH above their CACs. As noted earlier, tumors tissues are 
more acidic than normal tissues. For this reason, a pH of 7.0 was selected to assess how the 
concentration-dependent transition from nanofiber to micelle affected relaxation times. T1 
relaxivity (r1) was determined according to the equation 
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Figure 10: Gold stars show approximate concentrations and 
pHs of T1 values acquired for PA 4 
1/T1 = 1/T1,d + r1[contrast agent] 
 
 where 1/T1,d corresponds to salt solution proton relaxation time in the absence of the 
paramagnetic contrast agent, PA(DO3A:Gd). 
 The r1 values for PAs 1 – 6 are provided in Table 2. Here, we can see that the relaxivity 
of nanofibers at pH 5.2 and 7.0 are all within 10% of each other, indicating that  they exhibit 
similar relaxation activities. Moreover, we can see that all nanofibrous relaxivities are 
significantly higher than their micellar counterparts. This is due to an increased rotational 
correlation time of the PA(DO3A:Gd) with the water lattice as a result of the higher molecular 
weight and slower tumbling time of the nanofiber morphology.  
PA # pH 5.2 
Nanofiber r1 
pH 7.0 
Nanofiber r1 
pH 7.0 
Micelle r1 
PA 1 10.51 10.58 - 
PA 2 10.24 9.95 4.89 
PA 3 9.51 8.49 5.09 
PA 4 10.19 9.33 7.65 
PA 5 8.53 8.54 5.69 
PA 6 9.60 9.09 6.47 
 
Table 2: r1 values for the PAs 
 
 Similarly, we see that, although E5 PAs 2 & 5 have larger molecular weights and 
increased diameters as compared to their E4 PAs 1 &4 counterparts, they have lower r1 values. 
This may be due to additional degrees of freedom offered by the additional charged amino acid 
in the charged region. These results are promising because they show that PA(DO3A:Gd) exhibit 
increased relaxivity compared to an FDA-approved Prohance/Gadoteridol control (r1 = 4.1 L 
mmol
-1
 s
-1
)
14
. 
 
 Chapter 6: Conclusions and Future Work 
 
 In conclusion, we have shown the ability to tune the self-assembly behavior of PAs in an 
isotonic salt solution by chemically modifying the hydrophobic tail, β-sheet forming, and 
charged regions. Since PA 1 was seen to have too great attractive forces which induced a 
morphology of nanofibers at all concentrations and pHs, the following effects were found to 
decrease these repulsive forces to induce micelle formation: shortening the hydrophobic tail 
(palmitoyl to pentadecyl), substituting amino acids in the β-sheet forming region for amino acids 
that have a lesser propensity to form β-sheets (YYAA to YAAA), and adding an additional 
charged amino acid in the charged region (EEEE to EEEEE). An immediate need of this project 
is to acquire cryo-TEM images of PAs 5 & 6 to better visualize the morphologies of the 
molecules. Similarly, we may desire to recollect the CD data for PA 6. 
 It is worth noting that PAs 1 – 6 would not make for ideal transitioning vehicles in vivo. 
Foremost, their pHs of transition on the whole are too low in comparison to an ideal transitioning 
pH near 6.8 – 7.0. However, the primary reason to not use these tyrosine-containing PAs is their 
remarkable concentration dependence, as seen by the higher horizontal lines in the phase 
diagrams. A more ideal PA’s self-assembly would be concentration independent, that is, the PA 
will always transition from micelle to nanofiber at a specific pH regardless of the concentration. 
For instance, recent unpublished murine in vivo experiments require the injection concentration 
of PA to be >1mM – because the animals are only 20-25g – at which PAs 1 – 6 would firmly be 
nanofibers. While the PAs will dilute to roughly 50 μM by the time they reach the tumor site, 
injecting micelles would be kinetically simpler. Nevertheless, a complete biodistribution study 
with PA-DO3A:Gd will be necessary to more fully understand the future direction of this 
project. 
 We have found that a similar palmitoyl-MAAAEEEEK(DO3A:Gd) system is too small 
and overwhelmingly accumulates in the kidneys and organs with strong immune system activity, 
such as the lungs, spleen, and liver. This is indicative a small hydrodynamic radius and uptake by 
the mononuclear phagocyte system (MPS). To counteract these conditions, addition of 
polyethylene glycol (PEG) could be used. PEG is a ubiquitous, FDA-approved polymer used to 
coat biomaterials such as proteins, micelles, liposomes. Adding PEG will require additional 
considerations as to how adding a bulky hydrophilic, polydisperse group to the periphery of the 
PA affects self-assembly. Moreover, chain length and graft density – the percent of molecules 
within a micelle that contain the PEG – will further complicate this analysis. Regardless, 
PEGylation will be a vital component in the development of this next-generation contrast agent. 
 
 
 
 
 
 
 
 
 
 
 
Chapter 7: Supporting Information 
Mass Spectrometry 
PA 5: palmitoyl-YAAAEEEEEK(DO3A:Gd)-NH2 (Exact Mass: 1945.82 g/mol) 
 
PA 6: pentadecyl-YAAAEEEEK(DO3A:Gd)-NH2 (Exact Mass: 1802.76 g/mol) 
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Circular Aggregation Concentration 
CAC for PA 5 pH 5 in 150 mM NaCl and 2.2 mM CaCl2 
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Table of CACs for PAs 2 – 6 
(in μM) 
 
pH PA 2 PA 3 PA 4 PA 5 PA 6 
5 0* 0* 7.28 4.87 5.50 
6 5.62 1.18 11.31 13.89 11.72 
7 9.37 3.89 14.08 15.11 13.79 
8 12.58 12.04 
 
15.93 14.71 
9 21.59 25.47 15.45 16.39 15.69 
 
*below the detectable limit 
 
 
Dynamic Light Scattering 
PA 2 – pH 10.2 50 µM in salt solution 
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PA 3 – pH 10.5 50 µM in salt solution 
 
PA 4 – pH 10.6 50 µM in salt solution 
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PA 5 – pH 10.5 50 µM in salt solution 
 
PA 6 – pH 10.8 40 µM in salt solution 
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Chapter 8: Materials and Methods 
Synthesis of Peptide Amphiphiles (PA):   
All amino acids and coupling agents were purchased from AnaSpec INC.  The peptides 
were synthesized via solid-phase Fmoc chemistry.  The peptide sequence was built C-Terminus 
to N-Terminus using a Seiber Amide Resin (AAPPTEC) on a 0.3 mmol scale. All of the 
prepared PAs were synthesized manually as outlined in the following paragraph. 
The resin was placed in a shaker vessel and then swollen with dichloromethane (DCM) 
for 30 minutes.  The DCM was removed, and then N, N-Dimethylformanide (DMF) was added 
to the shaker vessel to swell the resin for 30 minutes.  20% piperidine in DMF was added for the 
deprotection of the Fmoc protecting group and allowed to shake for 15 minutes.  The liquid was 
removed, and replenished to shake for another 15 minute interval. The piperidine/DMF solution 
was removed and washed with DCM, DMF (2x) and DCM (2x) sequentially.  The removal of the 
Fmoc protecting group was confirmed via a Kaiser Test. The coupling solution for each amino 
acid contained 4 eq. of O-Benzotriazole N,N,N’,N’-tetramethyluroniumhexafluorophosphate 
(HBTU) or 2-(7-Aza-1H-benzotriazole-1-ly)-1,1,3,3- tetramethyluronium hexafluorophosphate 
(HATU), 3.95 eq. of amino acid, 6 eq. of N,N- diisopropylethylamine (DIPEA) and 2 drops of 
Triton X-100 in approximately 10mL of DMF.  This solution was added to the shaker vessel and 
allowed to couple for 3 hours to the deprotected species (amino acid or resin).  The solution was 
then removed, and the resin was washed with DMF (3x) followed by DCM (2x). The coupling of 
the amino acid was confirmed by another Kaiser Test.  This process was repeated for each amino 
acid as well as the palmitic or pentadecanoic acid tail. 
 
 
Attachment of DO3A to PAs: 
A solution containing 10% hydrazine in DMF was prepared and added to the resin in the 
shaker vessel to deprotect the 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl 
(ivDde) group from the side chain of the lysine. The vessel was shaken for 20min, the solution 
drained, and this process was repeated twice more for a total of three washes. A coupling 
solution containing 2 eq. HATU, 2 eq. 1,4,7- tris(carboxymethylaza)cyclododecane-10-
azaacetylamide (DO3A), 4.4 eq. DIPEA (relative to the PA) were added to the shaker vessel.  
The mixture was then set to stir for 18-24 hours at room temperature.  To ensure maximal 
coupling, excess solvent was removed under vacuum, until only 10-15 mL of the mixture 
remained.  A second coupling mixture of 2 eq. HATU, 4.4 eq. DIPEA and 1 mL of pyridine was 
added to the PA and stirred for 18-24 hours.   
 
Resin Cleavage and removal of tert-butyl groups on PA: 
A 20 mL solution containing 95% TFA, 3% water and 2% Anisole was prepared and 
added to the PA-DO3A. The mixture was set to stir for 20-24 hours at room temperature in order 
to remove tert-butyl groups from the glutamic acid, tyrosine and DO3A species.  Excess TFA 
was removed under vacuum and the PA-DO3A was crashed out with cold diethyl ether. The 
mixture was cooled at -5°C for 45 minutes and the resulting solid was isolated via filtration. 
 
Purification of PA-DO3A: 
The crude PA-DO3A (150-250 mg) was dissolved in a 10 mL solution consisting of 9 
mL of water, 1 mL of acetonitrile and a few drops of NH4OH.  This solution was, shaken, 
sonicated and vortexed to ensure full dissociation.  The resulting solution was then filtered 
through a 0.45 µm PVDF filter.  Purification of the PA-DO3A was carried out using a Shimadzu 
preparative High Performance Liquid Chromatograph (HPLC) duel pump system controlled by 
LC-MS solution software, with an Agilent PLRP-S polymer column (Model No. PL1212.3100 
150 mm x 25 mm).  The two solvents that were used for the mobile phase were water with 0.1% 
NH4OH (v/v) and acetonitrile with 0.1%NH4OH (v/v).  The product was eluted via a linear 
gradient from 10% acetonitrile to 20% acetonitrile over 22.5 minutes, and then from 20% 
acetonitrile to 40% acetonitrile over an additional 67.5 minutes.  The desired product was 
collected in fractions of 10-15 mL. The presence of the product in the fractions was confirmed 
by a Bruker Electrospray Ionization Time of Flight Mass Spectrometry (ESI-TOF MS) and the 
purity by Shimadzu analytical HPLC.  Fractions   95% in purity were added together, 
acetonitrile was removed under vacuum and the liquid fraction were freeze-dried yield a white 
powder.   
 
Incorporation of Gd
3+
 in PA-DO3A: 
The pure PA-DO3A was dissolved in 4-6 mL of water.  2 eq. of 0.01M GdCl3 in 0.01M 
HCl were added to the PA-DO3A solution.  Diluted NaOH(aq) was added to this solution to set 
the pH at 5.0 - 5.1.  The solution was placed in an oil bath to stir at 60°C.  After 60 minutes, the 
solution was removed from the oil bath, the pH was readjusted to a value of 5.0 – 5.1, and then 
placed back in the hot oil bath to stir for 12-18 hours. The solution was then returned to room 
temperature and the pH was raised to a value greater than 10 using 1 M NaOH to precipitate out 
all non-chelated Gd
3+
 to produce solid Gd(OH)3.  The solution was filtered with a 0.45 µm 
PVDF filter and the pH was lowered to a neutral value of approximately 7. 
 
Dialysis of the PA-(DO3A:Gd): 
The PA-(DO3A:Gd) solution was pipetted into a Spectra/Por® Biotech Cellulose Ester 
dialysis membrane (molecular weight cut off: 500 g/mol) and placed in 4 L of Millipore water.  
The water was changed 5 – 8 times over a 72 hour period.  The dialyzed solution was then 
lyophilized. The resulting solid yielded the pure PA-(DO3A:Gd)  powder which was confirmed 
through ESI- TOF MS and analytical HPLC. 
 
Circular Dichorism (CD): 
The PA-(DO3A:Gd) solid was dissolved in a aqueous solution of 150 mM NaCl and 2.2 
mM CaCl2, to yield a 0.5 – 1 mM peptide solution.  The resulting solution was then used to 
create diluted samples that included 500, 300, 100, 50, 30 and 10 µM.  The pH was raised in 
each of the solutions to a value greater than 9, stirred in an oil bath at 90 °C for 30 minutes, and 
then cooled to room temperature.  CD measurements were conducted on a JASCO J-815 
Spectrometer using a 0.5 or 1 cm path length quartz cuvette. Three accumulation were measured 
at a wavelength range of 260 – 190 nm at a scanning speed of 100 nm/min with an integration 
time of 2 or 4 seconds for each data series. A baseline (aqueous salt solution) was subtracted 
from each of the measurements.  Each molecule in this study was analyzed with these parameters 
at a range of concentration and pH values.  
 
Critical Aggregation Concentration (CAC): 
CAC for the synthesized molecules were determined using the pyrene 1:3 method
23
. CAC 
measurements were taken at pH points of 5, 6, 7, 8, and 9 for each of the molecules tested. 5 mg 
of pyrene were dissolved and mixed in methanol overnight and then diluted with NaCl, CaCl2 
aqueous solutions, and excess water to yield a solution of 150 mM NaCl, 2.2 mM CaCl2 and 62 
µM pyrene. 
For the 500 µM PA-(DO3A:Gd) solution, the pH was raised to a value greater than 9, 
stirred in an oil bath at 90 °C for 30 minutes, and then cooled to room temperature. A 300 µM 
sample was made from this solution.  250 µL of both the 500 µM and 300 µM solutions were 
serial diluted with 150 mM NaCl 2.2 CaCl2 mM aqueous solution. Each of the starting 
concentrations and the diluted mixtures were added to a 96-microwell plate.  5 µL of the pyrene 
solution was added to each of the wells and then stirred ensure homogeneity.  All of the 
components added to make the samples were at the same pH value in order to test the CAC.  The 
fluorescence emission of the pyrene was monitored by a BioTek Synergy H4 fluorimeter at an 
excitation wavelength of 335 nm. The pyrene fluorescence was monitored from 360 nm to 430 
nm, and the peaks of maximum fluorescence intensity (usually at 376 nm and 392 nm were 
compared at different concentration values to determine the CAC at a specific pH value.   
 
Dynamic Light Scattering (DLS): 
 PA was dissolved in 150 mM NaCl, 2.2 mM CaCl2 and filtered with 250nm filters, and 
sonicated. The resulting solutions were adjusted to appropriate concentrations and pHs such that 
they exhibited a micelle morphology (typically 50 μM and pH = 10.5). DLS measurements were 
performed using a Malvern Nano series Zetasizer.  
 
T1 Relaxivity (r1): 
Various concentrations of PA-DO3A:Gd in 150 mM NaCl and 2.2 mM CaCl2 were 
prepared to acquire low-field spin−lattice (T1) relaxation time measurements at different pH 
values on a benchtop minispec mq20. A permanent magnet created a field (0.469 T) 
corresponding to a proton resonance frequency of 19.95 MHz. The sample temperature was kept 
at 40 °C. For all samples, the magnetic field was matched to the resonance circuit, and the 
durations were on the order of 2.8 and 5.6 μs at full amplitude for π/2- and π-pulses, respectively. 
The inversion−recovery pulse sequence was used to measure the 1 H T1 relaxation times in the 
laboratory frame. In this pulse sequence, the bulk magnetization is inverted by a 180° radio 
frequency pulse and then allowed to recover to equilibrium via the T1 relaxation process over a 
variable recovery time, before acquisition of the free-induction decay with 32 data points and 16 
scans per point. A recycle delay time of >5 T1 was used to allow the system to fully relax 
between FID acquisitions, and phase cycling was employed to eliminate signal artifacts. 
Relaxivity (r1) values were then obtained from the slopes of 1/T1 vs PA:Gd(DO3A) plots. 
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